United States - The Cancer Letter - Annual Institution-wide Online Subscription to Cancer Research

For more information and to make a bid you will need to go to the third party website.


Provided by Open Opps
Opportunity closing date
14 August 2019
Opportunity publication date
06 August 2019
Value of contract
to be confirmed
Your guide to exporting
Report opportunity


Added: Aug 05, 2019 11:51 am

  Title: The Cancer Letter - Annual Institution-wide Online Subscription to Cancer Research and
Drug Development Content

Document Type: Combined Synopsis / Solicitation Notice
Solicitation Number: 75N91019R00035
Proposed Posted Date: 8/5/2019
Proposed Response Date: 8/14/2019
Classification Code: T - Photographic, Mapping, Printing, and Publications
NAICS Code: 511120 - Periodical Publishers
Business Size Standard: 1000 Employees
Contracting Office Address
Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E122, Bethesda, MD 20892, UNITED STATES.
Non-USPS mail such as Fedex UPS and other private carriers please use Rockville, MD 20850.
The National Cancer Institute (NCI), Office of Communications and Public Liaison (OCPL), Office of Acquisitions (OA) plans to procure an annual institution-wide online subscription to cancer research and drug development content.
This is a combined synopsis/solicitation for commercial items, prepared in accordance with format in FAR 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation and a separate written solicitation will not be issued. This solicitation: No. 75N91019R00035 includes all applicable provisions and clauses in effect through FAR FAC 2019-03 (July 2019) simplified procedures for commercial items.
The North American Industry Classification System code is 511120 and the business size standard is 1000 employees.
Only one award will be made as a result of this solicitation. This will be awarded as a
severable firm fixed price type contract.
The base period of performance shall be for a twelve (12) months base period with
one (1) 12-month option period.
Base Period: September 21, 2019 through September 20, 2020
Option Period 1: September 21, 2020 through September 20, 2021
I. Description of Requirement
The following product features/characteristics are required. The information must be presented in a newsletter format with new and updated information on a weekly basis:
1.1 12 - months of access
1.2 Access for 3,000 - 4,000 users
1.3 24/7 timely, Quality Access of current and archived cancer content
1.4 Online support shall be available during normal business hours of operation
(Mon - Fri) 8am - 5pm EST
1.5 Confirmation of each NCI online user access setup.
1.6 Quarterly report of active or inactive users, including:
Unique Visitors
The Number of Visits
Page Views
1.7 IP verification for access instead of username/password
1.8 Weekly updates to cancer-related content
1.9 Listing of cancer research funding opportunities
1.10 Summarization of NCI grant opportunities and awards
1.11 Summarization of FDA grant opportunities and awards
1.12 Summarization of Rare Disease drug designations
1.13 Presentation of legislative issues surrounding cancer research and funding
1.14 Summarization of FDA approved cancer drugs
1.15 Listing and summary of NCI approved trials - monthly
1.16 Summary of cancer related industry trials
1.17 Detailed summary of Phase III clinical trial results
1.18 Downloadable PDF versions of weekly content
1.19 Bonus access to clinical trial information
Shall the subscription services be delayed or canceled by the subscription source due to weather, server trouble, or internet provider issues the Contractor shall provide notification by phone or email to the Technical Point of Contact (TPOC), upon receipt of notice from the subscription source, the Contractor shall within two hours furnish a schedule for re-establishment of online access.
II. Delivery: Contractor shall deliver the item(s) within 6 weeks after award to: NIH/NCI Bethesda, Maryland 20892. The Contractor that receives the award will be provided with the complete mailing address and point of contact. Upon award, contractor must notify the NCI Technical Point of Contact to schedule the delivery.
III. Payment: Payment shall be made after delivery and acceptance by the Technical Point of Contact. Payment authorization requires submission and approval of invoice by the NCI TPOC and NIH Commercial Accounts.
QUESTIONS ARE DUE: August 9, 2019
The purchase order will be awarded to the Lowest Price Technically Acceptable (LPTA). The award will be made on the basis of the lowest evaluated price of quotations meeting or exceeding the acceptability standards for the requirements/technical specifications stated above. The technical evaluation will be a determination based on information furnished by the vendor. The Government is not responsible for locating or securing any information which is not identified in the quote. The Government reserves the right to make an award without discussions.
PROVISIONS AND CLAUSES: The following FAR provisions and clauses apply to this acquisition:
52.212-1 Instructions to Offerors Commercial Items (Oct 2018);
52.212-2 Evaluation Commercial Items (OCT 2014):
FAR Clause 52.212-5: CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT STATUTES OR EXECUTIVE ORDERS-COMMERCIAL ITEMS (May 2019). The following FAR clauses cited in paragraph (b) of the clause at FAR 52.212-5 are also applicable to this acquisition;
FAR Clause 52.203-6, Restrictions on Subcontractor Sales to the Government (Sept 2006)
FAR Clause 52.204-10, Reporting Executive Compensation and First-Tier Subcontract Awards (Oct 2018)
FAR Clause 52.209-6, Protecting the Government's Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment. (Oct 2015)
FAR Clause 52.219-4, Notice of Price Evaluation Preference for HUBZone Small Business Concerns (Oct 2014)
FAR Clause 52.219-6, Notice of Total Small Business Aside (Nov 2011) (15 U.S.C. 644)
FAR Clause 52.219-28, Post Award Small Business Program Representation (Jul 2013)
FAR Clause 52.222-3, Convict Labor (June 2003)
FAR Clause 52.222-19, Child Labor-Cooperation with Authorities and Remedies (Jan 2018)
FAR Clause 52.222-21, Prohibition of Segregated Facilities (Apr 2015)
FAR Clause 52.222-26, Equal Opportunity (Sep 2016)
FAR Clause 52.222-35, Equal Opportunity for Veterans (Oct 2015)
FAR Clause 52.222-36, Equal Opportunity for Workers with Disabilities (Jul 2014)
FAR Clause 52.222-37, Employment Reports on Veterans (Feb 2016)
FAR Clause 52.222-40, Notification of Employee Rights Under the National Labor Relations Act (Dec 2010)
FAR Clause 52.223-18, Encouraging Contractor Policies to Ban Text Messaging While Driving (AUG 2011)
FAR Clause 52.225-1, Buy American Act--Supplies (May 2014)
FAR Clause 52.225-3, Buy American-Free Trade Agreements-Israeli Trade Act (May 2014)
Alternate II (May 2014) of 52.225-3
FAR Clause 52.225-13, Restrictions on Certain Foreign Purchases (June 2008)
FAR Clause 52.232-33, Payment by Electronic Funds Transfer-System for Award Management
(Oct 2018)
Full text copies of the representations and certifications for other cited provisions and clauses may be obtained online at the NCI website at http://ncioa.cancer.gov/oa-internet/ or from David Romley, Contract Specialist at David.Romley@nih.gov
OFFERORS: Offers must be submitted on an SF-1449 with a completed 52.212-3 Offeror Representations and Certifications-Commercial Items-with DUNS Number Addendum, signed by an authorized representative of the offeror OR provide a copy of the valid certification registrations of the offeror's Central Contractor Registration (CCR) and Online Representations and Certifications Applications (ORCA) through www.sam.gov.
Quotations must be received in the NCI-OA contracting office by 12:00 p.m. EST on
August 14, 2019. Please refer to solicitation number 75N91019R00035 on all correspondence. Faxed quotations will NOT be accepted. Quotations may be submitted via email to David Romley, Contract Specialist at David.Romley@nih.gov.
All questions shall be in writing and may be addressed to the aforementioned individual noted above. In order to receive an award, contractors must be registered and have valid certification in the System for Award Management through sam.gov.

Opportunity closing date
14 August 2019
Value of contract
to be confirmed

About the buyer

Department of Health and Human Services National Cancer Institute, Office of Acquisitions - Shady Grove United States

The deadline to apply for this opportunity has passed.
Visit the opportunities page to find another.

Is there anything wrong with this page?